• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高 pATM 与接受放疗的声门上型癌症局部控制不良相关。

High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy.

机构信息

Department of Otorhinolaryngology/Head and Neck Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Laryngoscope. 2020 Aug;130(8):1954-1960. doi: 10.1002/lary.28641. Epub 2020 Apr 10.

DOI:10.1002/lary.28641
PMID:32275333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7384019/
Abstract

OBJECTIVES

Most early stage laryngeal squamous cell carcinomas (LSCC) are treated with radiotherapy. Discovery of new biomarkers are needed to improve prediction of outcome after radiotherapy and to identify potential targets for systemic targeted therapy. The ataxia telangiectasia mutated (ATM) gene plays a critical role in DNA damage response induced by ionizing radiation.

METHODS

The prognostic value of immunohistochemical expression of pATM, pChk2, and p53 were investigated in 141 patients with T1-T2 LSCC curatively treated with external beam radiotherapy. Uni- and multivariable Cox regression analyses were performed to examine the relation between expression levels of markers and local control.

RESULTS

Local control was significantly worse in cases with high levels of pATM (HR 2.14; 95% CI, 1.08-4.24; P = .03). No significant associations with local control were found for pChk2 and p53 expression. The association of high pATM expression with poor local control was only found for supraglottic LSCC (HR 10.9; 95% CI, 1.40-84.4; P = .02).

CONCLUSION

Our findings suggest a potential role for ATM in response to radiotherapy in early stage supraglottic LSCC and imply ATM inhibition as a possibility to improve response to radiotherapy.

LEVEL OF EVIDENCE

NA Laryngoscope, 130: 1954-1960, 2020.

摘要

目的

大多数早期喉鳞状细胞癌(LSCC)采用放射治疗。需要发现新的生物标志物,以提高放疗后预测结果的能力,并确定潜在的系统靶向治疗靶点。共济失调毛细血管扩张突变(ATM)基因在电离辐射诱导的 DNA 损伤反应中起着关键作用。

方法

对 141 例 T1-T2 LSCC 患者进行了外照射放疗的治疗,检测 pATM、pChk2 和 p53 的免疫组化表达的预后价值。采用单变量和多变量 Cox 回归分析来检测标志物表达水平与局部控制之间的关系。

结果

高 pATM 水平的病例局部控制明显较差(HR 2.14;95%CI,1.08-4.24;P = 0.03)。pChk2 和 p53 表达与局部控制无显著相关性。高 pATM 表达与局部控制不良的相关性仅见于声门上 LSCC(HR 10.9;95%CI,1.40-84.4;P = 0.02)。

结论

我们的研究结果表明 ATM 在早期声门上 LSCC 对放射治疗的反应中可能发挥作用,并暗示 ATM 抑制作为提高放射治疗反应的可能性。

证据水平

无。《喉镜》,130:1954-1960,2020。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/7384019/269ad06dcbc2/LARY-130-1954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/7384019/5ae51d48fc71/LARY-130-1954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/7384019/269ad06dcbc2/LARY-130-1954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/7384019/5ae51d48fc71/LARY-130-1954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1d22/7384019/269ad06dcbc2/LARY-130-1954-g002.jpg

相似文献

1
High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy.高 pATM 与接受放疗的声门上型癌症局部控制不良相关。
Laryngoscope. 2020 Aug;130(8):1954-1960. doi: 10.1002/lary.28641. Epub 2020 Apr 10.
2
Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.磷酸化FADD对接受放疗的T1-T2声门上型喉癌的局部控制无预后价值。
Laryngoscope. 2017 Sep;127(9):E301-E307. doi: 10.1002/lary.26563. Epub 2017 Mar 17.
3
Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.声门型和喉咽型 T1-T2 癌的不同生物标志物谱和临床特征。
Laryngoscope. 2020 Dec;130(12):2825-2832. doi: 10.1002/lary.28532. Epub 2020 Feb 17.
4
Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.HIF-1a、CA-IX 和 OPN 在 T1-T2 喉癌放疗中的预后意义。
Laryngoscope. 2013 Sep;123(9):2154-60. doi: 10.1002/lary.23831.
5
Is p53 an independent prognostic factor in patients with laryngeal carcinoma?p53是否为喉癌患者的独立预后因素?
Cancer. 1998 Jan 15;82(2):286-91. doi: 10.1002/(sici)1097-0142(19980115)82:2<286::aid-cncr7>3.0.co;2-p.
6
[Expressions of SMG-1, ATM and P53 in laryngeal squamous cell carcinoma and their clinical significance].[SMG-1、ATM及P53在喉鳞状细胞癌中的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jan;36(1):50-5.
7
High DNMT1 Is Associated With Worse Local Control in Early-Stage Laryngeal Squamous Cell Carcinoma.高 DNMT1 与早期喉鳞状细胞癌局部控制不良相关。
Laryngoscope. 2022 Apr;132(4):801-805. doi: 10.1002/lary.29833. Epub 2021 Aug 24.
8
Overexpression of p53 protein does not predict local-regional control or survival in patients with early-stage squamous cell carcinoma of the glottic larynx treated with radiotherapy.p53蛋白过表达并不能预测接受放疗的早期声门鳞状细胞癌患者的局部区域控制情况或生存率。
Int J Radiat Oncol Biol Phys. 1998 Apr 1;41(1):37-42. doi: 10.1016/s0360-3016(98)00025-x.
9
ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.ATM、BCL2和TGFβ基因多态性作为头颈部鳞状细胞癌患者放疗结果的生物标志物
Genet Test Mol Biomarkers. 2017 Dec;21(12):727-735. doi: 10.1089/gtmb.2017.0180. Epub 2017 Nov 14.
10
Standardised Ki-67 proliferation index assessment in early-stage laryngeal squamous cell carcinoma in relation to local control and survival after primary radiotherapy.早期喉鳞状细胞癌中 Ki-67 增殖指数的标准化评估与原发放疗后局部控制和生存的关系。
Clin Otolaryngol. 2020 Jan;45(1):12-20. doi: 10.1111/coa.13449. Epub 2019 Nov 5.

引用本文的文献

1
ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects.毛细血管扩张性共济失调患者中有无类别转换重组缺陷时的ATM表达与激活情况。
J Clin Immunol. 2025 Jan 24;45(1):67. doi: 10.1007/s10875-025-01857-3.
2
Bladder Cancer Treatments in the Age of Personalized Medicine: A Comprehensive Review of Potential Radiosensitivity Biomarkers.个性化医疗时代的膀胱癌治疗:潜在放射敏感性生物标志物的综合综述
Biomark Insights. 2024 Nov 6;19:11772719241297168. doi: 10.1177/11772719241297168. eCollection 2024.
3
CD44, γ-H2AX, and p-ATM Expressions in Short-Term Ex Vivo Culture of Tumour Slices Predict the Treatment Response in Patients with Oral Squamous Cell Carcinoma.

本文引用的文献

1
State-of-the-art strategies for targeting the DNA damage response in cancer.针对癌症中 DNA 损伤反应的最新策略。
Nat Rev Clin Oncol. 2019 Feb;16(2):81-104. doi: 10.1038/s41571-018-0114-z.
2
Treatment of early stage Supraglottic squamous cell carcinoma: meta-analysis comparing primary surgery versus primary radiotherapy.早期声门上型鳞状细胞癌的治疗:比较原发性手术与原发性放疗的荟萃分析。
J Otolaryngol Head Neck Surg. 2018 Mar 5;47(1):19. doi: 10.1186/s40463-018-0262-2.
3
Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.
肿瘤切片短期体外培养中 CD44、γ-H2AX 和 p-ATM 的表达可预测口腔鳞状细胞癌患者的治疗反应。
Int J Mol Sci. 2022 Jan 14;23(2):877. doi: 10.3390/ijms23020877.
4
High DNMT1 Is Associated With Worse Local Control in Early-Stage Laryngeal Squamous Cell Carcinoma.高 DNMT1 与早期喉鳞状细胞癌局部控制不良相关。
Laryngoscope. 2022 Apr;132(4):801-805. doi: 10.1002/lary.29833. Epub 2021 Aug 24.
5
Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.喉鳞状细胞癌:基于免疫相关基因的潜在分子机制及预后特征
Med Sci Monit. 2020 Dec 26;26:e928185. doi: 10.12659/MSM.928185.
T1b期声门型鳞状细胞癌治疗中的治疗方式与肿瘤学结局:一项系统评价
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4091-4102. doi: 10.1007/s00405-017-4736-z. Epub 2017 Sep 19.
4
An update on larynx cancer.喉癌研究进展。
CA Cancer J Clin. 2017 Jan;67(1):31-50. doi: 10.3322/caac.21386. Epub 2016 Nov 29.
5
Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent - A population based study from the DAHANCA group.5001例接受根治性治疗的声门鳞状细胞癌患者的失败模式——丹麦头颈癌组的一项基于人群的研究
Radiother Oncol. 2016 Feb;118(2):257-66. doi: 10.1016/j.radonc.2016.02.006. Epub 2016 Feb 17.
6
Sodium glycididazole enhances the radiosensitivity of laryngeal cancer cells through downregulation of ATM signaling pathway.缩水甘油硝唑钠通过下调ATM信号通路增强喉癌细胞的放射敏感性。
Tumour Biol. 2016 May;37(5):5869-78. doi: 10.1007/s13277-015-4278-1. Epub 2015 Nov 9.
7
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.AZD7762(一种检查点激酶抑制剂)联合吉西他滨治疗美国晚期实体瘤患者的 I 期剂量递增研究。
Cancer Chemother Pharmacol. 2014 Mar;73(3):539-49. doi: 10.1007/s00280-014-2380-5. Epub 2014 Jan 22.
8
Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.HIF-1a、CA-IX 和 OPN 在 T1-T2 喉癌放疗中的预后意义。
Laryngoscope. 2013 Sep;123(9):2154-60. doi: 10.1002/lary.23831.
9
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours.AZD7762 单药及联合吉西他滨治疗日本晚期实体瘤患者的 I 期剂量递增研究。
Cancer Chemother Pharmacol. 2013 Sep;72(3):619-27. doi: 10.1007/s00280-013-2234-6. Epub 2013 Jul 28.
10
The role of ATM and 53BP1 as predictive markers in cervical cancer.ATM 和 53BP1 在宫颈癌中的预测标志物作用。
Int J Cancer. 2012 Nov 1;131(9):2056-66. doi: 10.1002/ijc.27488. Epub 2012 Mar 29.